Abstract LB-324: A toll-like receptor 4 agonist enhances the efficacy of trastuzumab therapy and promotes adaptive immunity and long-term protection against a human ErbB-2 (HER2)-transfected syngeneic tumor in a human HER2 transgenic mouse model
Keyword(s):
2015 ◽
Vol 46
◽
pp. 121-131
◽
2015 ◽
Vol 36
(2)
◽
pp. 730-739
◽
Keyword(s):
2017 ◽
Vol 65
(24)
◽
pp. 4970-4979
◽